Allergan’s Botox Approved for Lower Limb Spasticity in Pediatric Patients

Four months after being approved to treat pediatric patients with upper limb spasticity, Allergan’s Botox has been greenlit to treat pediatric patients with lower limb spasticity. This approval excludes patients whose spasticity is caused by cerebral palsy due to the exclusivity of another drug.